SCHEMBL18201113

SCHEMBL18201113

c1ccc(-c2ccc(-c3nc4ccccc4c4c3ccc3ccccc34)cn2)cc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 3/20 0.40
NPC1 O15118 2/20 0.40
LMNA P02545 1/20 0.40
RECQL P46063 1/20 0.40
RAB9A P51151 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
KDM4E B2RXH2 2/20 0.39
ALDH1A1 P00352 2/20 0.39
HPGD P15428 2/20 0.39
CYP11B1 P15538 1/20 0.39
CYP11B2 P19099 1/20 0.39
HPGDS O60760 1/20 0.38
PTGES O14684 1/20 0.38
ADORA2A P29274 1/20 0.36
NUDT1 P36639 1/20 0.36
DHODH Q02127 1/20 0.36
PIK3CD O00329 1/20 0.36
PIK3CA P42336 1/20 0.36
PIK3CB P42338 1/20 0.36
MTOR P42345 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18200547 0.91 MAPT (0.41) MAPTNPC1LMNARECQLRAB9A
SCHEMBL18200575 0.91 CYP11B1 (0.39) MAPTNPC1LMNARECQLRAB9A
SCHEMBL18201187 0.91 MAPT (0.38) MAPTNPC1LMNARECQLRAB9A
SCHEMBL21537777 0.90 PARP1 (0.38) MAPTNPC1LMNARECQLRAB9A
SCHEMBL18200544 0.90 MEN1 (0.44) MAPTNPC1LMNARECQLRAB9A
SCHEMBL18200545 0.89 MAPT (0.40) MAPTNPC1LMNARECQLRAB9A
SCHEMBL18200871 0.89 MAPT (0.40) MAPTNPC1LMNARECQLRAB9A
SCHEMBL18346940 0.89 DHODH (0.46) MAPTNPC1LMNARAB9AKDM4E
SCHEMBL18201042 0.88 MEN1 (0.39) MAPTNPC1LMNARECQLRAB9A
SCHEMBL18200475 0.88 HPGDS (0.41) MAPTNPC1LMNARAB9ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9728731-B2 Heterocyclic compound and organic light emitting device using same HEESUNG MATERIAL LTD. (KR) 2017-08-08 US disclosed
US-9728731-B2 Heterocyclic compound and organic light emitting device using same HEESUNG MATERIAL LTD. (KR) 2017-08-08 US disclosed
US-20160380208-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE USING SAME HEESUNG MATERIAL LTD. (KR) 2016-12-29 US disclosed
EP-3088392-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE USING SAME Heesung Material Ltd. (KR) 2016-11-02 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160380208-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE USING SAME NOTUM, DDT, CRY1 MAPT 1937/4885NPC1 3875/4885LMNA 3373/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.